Extensions, validation, and clinical applications of a feedback control system simulator of the hypothalamo-pituitary-thyroid axis

Thyroid

Volumn 18, Issue 10, 2008, Pages 1071-1085

  Eisenberg, Marisa ^a   Samuels, Mary ^b   DiStefano III, Joseph J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; THYROID HORMONE; THYROXINE;

ARTICLE; COMPARATIVE STUDY; COMPUTER SIMULATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG COMBINATION; DRUG DOSE REGIMEN; FEEDBACK SYSTEM; HORMONAL REGULATION; HORMONE METABOLISM; HYPOPHYSIS THYROID SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; INTRAMUSCULAR DRUG ADMINISTRATION; MONOTHERAPY; PARENTERAL DRUG ADMINISTRATION; PHARMACOKINETICS; PLASMA; PRIORITY JOURNAL; SIMULATOR; STEADY STATE; SUBCUTANEOUS DRUG ADMINISTRATION; SURGICAL PATIENT; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE;

BRAIN; COMPUTER SIMULATION; FEEDBACK; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHYROIDISM; IODIDE PEROXIDASE; KINETICS; MODELS, BIOLOGICAL; THYROID GLAND; THYROIDECTOMY; THYROXINE; TRIIODOTHYRONINE;

EID: 53649090210     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0388     Document Type: Article

References (42)

1. Eisenberg M, Samuels M, DiStefano JJ, 3rd 2006 L-T4 bioequivalence and hormone replacement studies via feedback control simulations. Thyroid 16:1279-1292.
2. Samuels MH, Henry P, Luther M, Ridgway EC 1993 Pulsatile TSH secretion during 48-hour continuous TRH infusions. Thyroid 3:201-206.
3. Kuku SF, Harsoulis P, Kjeld M, Fraser TR 1975 Human thyrotropic hormone kinetics and effects in euthyroid males. Horm Metab Res 7:54-59.
4. Odell WD, Utiger RD, Wilber JF, Condliffe PG 1967 Estimation of the secretion rate of thyrotropin in man. J Clin Invest 46:953-959.
5. Ridgway EC, Weintraub BD, Maloof F 1974 Metabolic clearance and production rates of human thyrotropin. J Clin Invest 53:895-903.
6. Visser TJ, Kaptein E, Terpstra OT, Krenning EP 1988 Deiodination of thyroid hormone by human liver. J Clin Endocrinol Metab 67:17-24.
7. Sharifi J, St. Germain DL 1992 The cDNA for the type I iodothyronine 5′-deiodinase encodes an enzyme manifesting both high Km and low Km activity. Evidence that rat liver and kidney contain a single enzyme which converts thyroxine to 3,5,3′-triiodothyronine. J Biol Chem 267:12539-12544.
8. Goswami A, Rosenberg IN 1988 Effects of glutathione on iodothyronine 5′-deiodinase activity. Endocrinology 123:192-202.
9. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38-89.
10. Blakesley VA, Awni W, Locke C, Ludden TM, Granneman GR, Braverman LE 2004 Are bioequivalence studies of levothyroxine sodium formulations in euthyroid volunteers reliable? Thyroid 14:191-200.
11. Barrett PH, Bell BM, Cobelli C, Golde H, Schumitzky A, Vicini P, Foster DM 1998 SAAM II: simulation, analysis, and modeling software for tracer and pharmacokinetic studies. Metabolism 47:484-492.
12. Jaquez JA, Greif P 1985 Numerical parameter identifiability and estimatability: integrating identifiability, estimatability, and optimal sampling design. Math Biosci 77:201-227.
13. Larsen PR 1982 Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones. N Engl J Med 306:23-32.
14. Larsen PR, Bavli SZ, Castonguay M, Jove R 1980 Direct radioimmunoassay of nuclear 3,5,3′ triiodothyronine in rat anterior pituitary. J Clin Invest 65:675-681.
15. Silva JE, Larsen PR 1978 Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats. Further evidence relating saturation of pituitary nuclear triiodothyronine receptors and the acute inhibition of thyroid-stimulating hormone release. J Clin Invest 61:1247-1259.
16. Larsen PR 1981 Regulation of thyrotropin secretion by 3,5,3′-triiodothyronine and thyroxine. Prog Clin Biol Res 74:81-93.
17. Larsen PR, Silva JE, Kaplan MM 1981 Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr Rev 2:87-102.
18. Silva JE, Larsen PR 1977 Pituitary nuclear 3,5,3′-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine. Science 198:617-620.
19. Bigos ST, Ridgway EC, Kourides IA, Maloof F 1978 Spectrum of pituitary alterations with mild and severe thyroid impairment. J Clin Endocrinol Metab 46:317-325.
20. DeGroot LJ, Hennemann G 2002 Thyroid disease manager: the thyroid and its diseases. http://www.thyroidmanager.org/thyroidbook.htm. Accessed September 2004.
21. Patel YC, Burger HG 1973 Serum triiodothyronine in health and disease. Clin Endocrinol (Oxf ) 2:339-349.
22. Patel YC, Pharoah PO, Hornabrook RW, Hetzel BS 1973 Serum triiodothyronine, thyroxine and thyroid-stimulating hormone in endemic goiter: a comparison of goitrous and nongoitrous subjects in New Guinea. J Clin Endocrinol Metab 37:783-789.
23. Wennlund A 1986 Variation in serum levels of T3, T4, FT4 and TSH during thyroxine replacement therapy. Acta Endocrinol (Copenh) 113:47-49.
24. Sarapura VD, Samuels MH, Ridgway EC 2002 Thyroid-stimulating hormone. In: Melmed S (ed) The Pituitary. Second edition. Blackwell Science, Malden, MA, pp 187-229.
25. Ueda S, Takamatsu J, Fukata S, Tanaka K, Shimizu N, Sakata S, Yamaji T, Kuma K, Ohsawa N 1996 Differences in response of thyrotropin to 3,5,3′-triiodothyronine and 3,5,3′-triiodothyroacetic acid in patients with resistance to thyroid hormone. Thyroid 6:563-570.
26. DiStefano JJ, 3rd, Mak PH 1979 On model and data requirements for determining the bioavailability of oral therapeutic agents: application to gut absorption of thyroid hormones. Am J Physiol 236:R137-R141.
27. Hays MT 2007 Parenteral thyroxine administration. Thyroid 17:127-129.
28. Hays MT, McGuire RA 1980 Distribution of subcutaneous thyroxine, triiodothyronine, and albumin in man: comparison with intravenous administration using a kinetic model. J Clin Endocrinol Metab 51:1112-1117.
29. Samuels MH, Lillehei K, Kleinschmidt-Demasters BK, Stears J, Ridgway EC 1990 Patterns of pulsatile pituitary glycoprotein secretion in central hypothyroidism and hypogonadism. J Clin Endocrinol Metab 70:391-395.
30. Huysmans DA, Nieuwlaat WA, Erdtsieck RJ, Schellekens AP, Bus JW, Bravenboer B, Hermus AR 2000 Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter. J Clin Endocrinol Metab 85:3592-3596.
31. Nielsen VE, Bonnema SJ, Hegedus L 2004 Effects of 0.9 mg recombinant human thyrotropin on thyroid size and function in normal subjects: a randomized, double-blind, cross-over trial. J Clin Endocrinol Metab 89:2242-2247.
32. Ramirez L, Braverman LE, White B, Emerson CH 1997 Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects. J Clin Endocrinol Metab 82:2836-2839.
33. Torres MS, Ramirez L, Simkin PH, Braverman LE, Emerson CH 2001 Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects. J Clin Endocrinol Metab 86:1660-1664.
34. Dietrich JW, Tesche A, Pickardt CR, Mitzdorf U 2002 Fractal properties of the thyrotropic feedback control implications of a nonlinear model compared with empirical data. In: Trappl R (Ed) Cybernetics and Systems. Austrian Society for Cybernetic Studies, Vienna, pp 329-34.
35. Dietrich JW, Tesche A, Pickardt CR, Mitzdorf U 2004 Thyrotropic feedback control: evidence for an additional ultrashort feedback loop from fractal analysis. Cybern Syst 35:315-331.
36. DiStefano JJ, 3rd, Stear EB 1968 Neuroendocrine control of thyroid secretion in living systems: a feedback control system model. Bull Math Biophys 30:3-26.
37. DiStefano JJ, 3rd, Stear EB 1968 On identification of hypothalamo-hypophysial control and feedback relationships with the thyroid gland. J Theor Biol 19:29-50.
38. Li G, Liu B, Liu Y 1995 A dynamical model of the pulsatile secretion of the hypothalamo-pituitary-thyroid axis. Biosystems 35:83-92.
39. Liu YW, Liu BZ, Xie JL, Liu YX 1994 A new mathematical-model of hypothalamo-pituitary-thyroid axis. Math Comput Model 19:81-90.
40. Fisher DA 1996 Physiological variations in thyroid hormones: physiological and pathophysiological considerations. Clin Chem 42:135-139.
41. Green WL 2005 New questions regarding bioequivalence of levothyroxine preparations: a clinician's response. AAPS J 7:E54-E58.
42. Samuels M, Luther M, Hentry P, Ridgway EC 1994 Effects of hydrocortisone on pulsatile pituitary glycoprotein secretion. JCEM 76:211-215.